Why FDA-backed gene therapy for singular form of blindness is revolutionary

October 13, 2017, 8:20 AM|
An initial gene therapy for a singular patrimonial form of blindness is a step closer to reality. An FDA advisory row voted unanimously Thursday to suggest capitulation of a groundbreaking diagnosis for people with a inadequate gene that impairs vision. It would be a initial gene therapy in a U.S. for an hereditary disease. Dr. David Agus joins “CBS This Morning” to plead how a diagnosis works and because it could be a new limit in treating genetic disorders.

Short URL: http://hitechnews.org/?p=36113

Posted by on Oct 13 2017. Filed under Health & Medicine. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Photo Gallery

Log in | Designed by hitechnews